Aptose Biosciences Inc (O:APTO)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for APTO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/20 Mar 25/20 Rice William G. Direct Ownership Common Shares P - Open market or private purchase 3,400 $5.82
Mar 13/20 Mar 11/20 Ashe Carol Gail Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Loewy Caroline M Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Burger Denis R Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Vincent Mark D. Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Platzer Erich Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Whitehead Warren Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Loewy Caroline M Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Burger Denis R Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Vincent Mark D. Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for APTO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 26/20 Mar 25/20 Rice William G. Direct Ownership Common Shares P - Open market or private purchase 3,400 $5.82
Mar 13/20 Mar 11/20 Ashe Carol Gail Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Loewy Caroline M Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Burger Denis R Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Vincent Mark D. Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Platzer Erich Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Whitehead Warren Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Loewy Caroline M Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Burger Denis R Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Mar 13/20 Mar 11/20 Vincent Mark D. Direct Ownership Director Option Grant A - Grant, award or other under Rule 16b-3(d) 50,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $APTO

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)